SILO Earnings
Latest RevenueN/A
Latest Net Income-832829
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.76 | 0 | -832829 | -100.0% | +73.6% |
| Q1 2026 | -$0.12 | 18.0K | -1647117 | +0.0% | +47.8% |
| Q4 2025 | -$0.05 | 18.0K | -881530 | +0.0% | +86.8% |
| Q3 2025 | -$0.12 | 18.0K | -1110438 | +0.0% | +45.5% |
| Q2 2025 | -$2.88 | 18.0K | -1204293 | +0.0% | -829.0% |
| Q1 2025 | -$0.23 | 18.0K | -1031437 | +0.0% | +17.9% |
| Q4 2024 | -$0.38 | 18.0K | -1730620 | +0.0% | +2.6% |
| Q3 2024 | -$0.22 | 18.0K | -928814 | +0.0% | -4.8% |
| Q2 2024 | -$0.31 | 18.0K | -931779 | — | — |
| Q1 2024 | -$0.28 | 18.0K | -801667 | — | — |
| Q4 2023 | -$0.39 | 18.0K | -1121176 | — | — |
| Q3 2023 | -$0.21 | 18.0K | -660160 | — | — |
Silo Pharma (SILO) — Earnings